Feedback / Questions
BBT002 - Bambusa Therapeutics
https://en.prnasia.com/releases/global/bambusa-therapeutics-presents-positive-preliminary-phase-1-bbt002-data-at-american-thoracic-society-2026-ats-2026-international-conference-and-announces-first-patient-dosed-in-phase-1b-2a-crswnp-trial-533429.shtml
May 18, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next